Back to INBX
GEODE CAPITAL MANAGEMENT, LLC → INBX
GEODE CAPITAL MANAGEMENT, LLC INBX Position History
Inhibrx Biosciences, Inc. • Healthcare
Quarters held
10
Latest value
$3.7M
Q3 2026
Peak value
$21.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6.5M |
| Q3 2025 | $970K |
| Q4 2025 | $15.5M |
| Q4 2025 | $2.4M |
| Q1 2026 | $13.3M |
| Q1 2026 | $2.2M |
| Q2 2026 | $20.9M |
| Q2 2026 | $3.3M |
| Q3 2026 | $21.9M |
| Q3 2026 | $3.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.7M | 36.9K | — | — |
| Q3 2026 | $21.9M | 218.4K | — | — |
| Q2 2026 | $3.3M | 35.3K | — | — |
| Q2 2026 | $20.9M | 220.8K | — | — |
| Q1 2026 | $2.2M | 33.4K | — | — |
| Q1 2026 | $13.3M | 198.1K | — | — |
| Q4 2025 | $2.4M | 30.5K | — | — |
| Q4 2025 | $15.5M | 195.6K | — | — |
| Q3 2025 | $970K | 28.8K | — | — |
| Q3 2025 | $6.5M | 193.1K | — | — |
Other funds holding INBX
$271.7M
$172.4M
$131.2M
$129.3M
$126.4M
$125.3M